Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06570122

Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents

This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Smoking Cessation Behavior Health Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beijing Normal University

Zhuhai, Guangdong, 519087, China

About this study

Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.

This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 18 and above, reside in Zhuhai for the next 6 months
  • smoke at least 1 cigarette or use e-cigarettes daily
  • have a smartphone and a WeChat account, able to use WeChat skillfully

Exclusion criteria

  • Smokers who have communication barrier (either physically or cognitively)
  • Smokers who are currently participating in other SC programmes or services

Treatment and study plan

5A's/5R's advice

Behavioral

5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.

Health warning leaflet

Other

The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.

AI-powered chatbot support

Behavioral

Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.

Primary outcomes

  1. Self-reported 7-day point prevalence quit rate

    Time frame: 3 and 6 months follow-up

    Self-reported 7-day point prevalence quit rate in the two groups

  2. Eligibility rate

    Time frame: baseline

    the percentage of eligible smokers out of the total number of smokers screened

Secondary outcomes

  1. Consent rate

    Time frame: baseline

    the percentage of eligible smokers who agree to participate out of the total number of eligible smokers

  2. Percentage of Participant Engagement with E-Messages and Counselor Chats

    Time frame: 3 months follow-up

    This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.

Study contacts

Contact information is provided by the study sponsor or research team.

Xue Weng

CONTACT

[email protected]

3621259

Sponsors and collaborators

Lead sponsor

Beijing Normal University

Other

Registry information

Official study title

Effectiveness of AI-powered Mobile Phone-based Interventions in Parental Smoking Cessation

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 26, 2024
Registry last updated
Aug 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.